Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Premature Birth | 5 | 2019 | 148 | 1.890 |
Why?
|
| Pre-Eclampsia | 7 | 2022 | 202 | 1.680 |
Why?
|
| Neuroprotective Agents | 3 | 2018 | 317 | 1.400 |
Why?
|
| Acetylcysteine | 4 | 2015 | 296 | 1.290 |
Why?
|
| Pregnancy | 18 | 2022 | 2331 | 0.890 |
Why?
|
| Uterus | 3 | 2015 | 77 | 0.890 |
Why?
|
| Esophageal Neoplasms | 4 | 2007 | 150 | 0.870 |
Why?
|
| Optic Nerve | 1 | 2022 | 55 | 0.830 |
Why?
|
| Adenocarcinoma | 4 | 2007 | 475 | 0.750 |
Why?
|
| Magnesium Sulfate | 1 | 2018 | 6 | 0.670 |
Why?
|
| Fetus | 2 | 2015 | 157 | 0.630 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2018 | 50 | 0.630 |
Why?
|
| Prenatal Care | 1 | 2018 | 117 | 0.630 |
Why?
|
| Infant, Premature, Diseases | 1 | 2018 | 85 | 0.610 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2007 | 170 | 0.600 |
Why?
|
| Fetal Growth Retardation | 2 | 2015 | 56 | 0.570 |
Why?
|
| Chorioamnionitis | 1 | 2015 | 40 | 0.530 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2015 | 79 | 0.510 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 40 | 0.510 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2015 | 91 | 0.480 |
Why?
|
| Fundoplication | 3 | 2007 | 27 | 0.440 |
Why?
|
| Microsatellite Instability | 2 | 2009 | 39 | 0.440 |
Why?
|
| Contractile Proteins | 1 | 2012 | 17 | 0.430 |
Why?
|
| Lymphocytes | 2 | 2009 | 228 | 0.410 |
Why?
|
| Infant, Newborn | 7 | 2020 | 2453 | 0.400 |
Why?
|
| Female | 28 | 2022 | 38015 | 0.390 |
Why?
|
| Barrett Esophagus | 3 | 2007 | 57 | 0.380 |
Why?
|
| Pregnancy Proteins | 2 | 2007 | 15 | 0.380 |
Why?
|
| Fetal Diseases | 1 | 2011 | 64 | 0.380 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2007 | 24 | 0.380 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 112 | 0.370 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 455 | 0.370 |
Why?
|
| Colonic Neoplasms | 2 | 2009 | 299 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 2222 | 0.340 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2007 | 15 | 0.310 |
Why?
|
| Heterocyclic Compounds | 1 | 2007 | 24 | 0.310 |
Why?
|
| Humans | 33 | 2022 | 68525 | 0.310 |
Why?
|
| Brain Injuries | 1 | 2011 | 268 | 0.300 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 74 | 0.300 |
Why?
|
| Placenta | 2 | 2020 | 101 | 0.300 |
Why?
|
| Organometallic Compounds | 1 | 2007 | 95 | 0.290 |
Why?
|
| Breast Neoplasms | 2 | 2006 | 1533 | 0.290 |
Why?
|
| Complementary Therapies | 1 | 2006 | 43 | 0.280 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 40 | 0.280 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 119 | 0.280 |
Why?
|
| RNA, Neoplasm | 1 | 2006 | 76 | 0.280 |
Why?
|
| Genomic Instability | 1 | 2006 | 41 | 0.280 |
Why?
|
| Incidence | 5 | 2015 | 1582 | 0.270 |
Why?
|
| Delivery, Obstetric | 2 | 2008 | 58 | 0.260 |
Why?
|
| Hyaline Membrane Disease | 1 | 2004 | 10 | 0.260 |
Why?
|
| Pregnancy, Multiple | 1 | 2004 | 32 | 0.240 |
Why?
|
| Rh Isoimmunization | 2 | 2013 | 6 | 0.240 |
Why?
|
| Contrast Media | 1 | 2007 | 594 | 0.240 |
Why?
|
| Rho(D) Immune Globulin | 2 | 2013 | 9 | 0.240 |
Why?
|
| Genotyping Techniques | 2 | 2013 | 19 | 0.240 |
Why?
|
| Gestational Age | 4 | 2020 | 389 | 0.230 |
Why?
|
| Unnecessary Procedures | 2 | 2013 | 49 | 0.230 |
Why?
|
| Survival Rate | 3 | 2015 | 1055 | 0.220 |
Why?
|
| Retrospective Studies | 9 | 2020 | 7264 | 0.220 |
Why?
|
| Biomarkers, Tumor | 1 | 2006 | 508 | 0.210 |
Why?
|
| Reproducibility of Results | 5 | 2015 | 2077 | 0.210 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 624 | 0.210 |
Why?
|
| Intracranial Hypertension | 1 | 2022 | 53 | 0.200 |
Why?
|
| Regression Analysis | 2 | 2022 | 737 | 0.200 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 560 | 0.190 |
Why?
|
| Myelin Sheath | 1 | 2021 | 115 | 0.190 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2020 | 44 | 0.190 |
Why?
|
| Amniotic Fluid | 1 | 2019 | 30 | 0.180 |
Why?
|
| Ultrasonography | 1 | 2022 | 453 | 0.180 |
Why?
|
| Adult | 8 | 2022 | 21375 | 0.180 |
Why?
|
| Gastroesophageal Reflux | 3 | 2006 | 318 | 0.180 |
Why?
|
| Hypertension | 2 | 2007 | 1531 | 0.180 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 132 | 0.180 |
Why?
|
| Wound Healing | 3 | 2006 | 260 | 0.170 |
Why?
|
| Treatment Outcome | 7 | 2018 | 7028 | 0.170 |
Why?
|
| Infant | 3 | 2020 | 2891 | 0.160 |
Why?
|
| Male | 12 | 2021 | 37281 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 1172 | 0.150 |
Why?
|
| Oregon | 2 | 2006 | 7 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2015 | 3702 | 0.140 |
Why?
|
| Risk Factors | 5 | 2009 | 5719 | 0.140 |
Why?
|
| Echoencephalography | 1 | 2015 | 10 | 0.140 |
Why?
|
| Neoplasm Staging | 3 | 2009 | 799 | 0.140 |
Why?
|
| Cohort Studies | 1 | 2022 | 2356 | 0.140 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 57 | 0.140 |
Why?
|
| Aged | 8 | 2021 | 14842 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 2 | 2006 | 107 | 0.130 |
Why?
|
| Logistic Models | 1 | 2018 | 1419 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1745 | 0.120 |
Why?
|
| Prognosis | 3 | 2009 | 2093 | 0.120 |
Why?
|
| Global Health | 1 | 2015 | 135 | 0.120 |
Why?
|
| Mothers | 1 | 2015 | 172 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 296 | 0.120 |
Why?
|
| Anastomosis, Surgical | 4 | 2006 | 104 | 0.120 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 157 | 0.120 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 1139 | 0.120 |
Why?
|
| Models, Animal | 2 | 2012 | 252 | 0.110 |
Why?
|
| Electroencephalography | 1 | 2015 | 418 | 0.110 |
Why?
|
| Middle Aged | 8 | 2021 | 21119 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 1753 | 0.110 |
Why?
|
| Animals | 9 | 2012 | 20877 | 0.110 |
Why?
|
| Receptors, Oxytocin | 1 | 2012 | 9 | 0.110 |
Why?
|
| Uterine Contraction | 1 | 2012 | 30 | 0.110 |
Why?
|
| Connexin 43 | 1 | 2012 | 62 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 1 | 2012 | 160 | 0.100 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1737 | 0.100 |
Why?
|
| Placenta Growth Factor | 2 | 2007 | 12 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2012 | 447 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2009 | 714 | 0.100 |
Why?
|
| Ischemia | 2 | 2009 | 229 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2012 | 432 | 0.090 |
Why?
|
| Labor, Induced | 1 | 2010 | 18 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2014 | 753 | 0.090 |
Why?
|
| Esophagectomy | 2 | 2006 | 26 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2011 | 396 | 0.090 |
Why?
|
| Single-Blind Method | 2 | 2007 | 249 | 0.090 |
Why?
|
| Conscious Sedation | 2 | 2006 | 61 | 0.090 |
Why?
|
| Mice | 2 | 2012 | 8472 | 0.090 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2009 | 8 | 0.090 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2009 | 25 | 0.090 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2009 | 20 | 0.090 |
Why?
|
| Gloves, Surgical | 1 | 2008 | 5 | 0.080 |
Why?
|
| Needlestick Injuries | 1 | 2008 | 10 | 0.080 |
Why?
|
| Adolescent | 2 | 2015 | 8903 | 0.080 |
Why?
|
| Lacerations | 1 | 2008 | 13 | 0.080 |
Why?
|
| Needles | 1 | 2008 | 34 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2008 | 75 | 0.080 |
Why?
|
| Models, Biological | 1 | 2012 | 981 | 0.080 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2007 | 58 | 0.080 |
Why?
|
| Laparoscopy | 2 | 2006 | 237 | 0.080 |
Why?
|
| Neoplasm, Residual | 1 | 2007 | 33 | 0.080 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 215 | 0.080 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2006 | 5 | 0.070 |
Why?
|
| Gadolinium | 1 | 2007 | 88 | 0.070 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2006 | 33 | 0.070 |
Why?
|
| Treatment Refusal | 1 | 2006 | 40 | 0.070 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2006 | 53 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1293 | 0.070 |
Why?
|
| Esophageal Diseases | 1 | 2006 | 95 | 0.070 |
Why?
|
| Cardia | 1 | 2006 | 4 | 0.070 |
Why?
|
| Digestive System Diseases | 1 | 2006 | 16 | 0.070 |
Why?
|
| Hospitals, Community | 1 | 2006 | 64 | 0.070 |
Why?
|
| Nose | 1 | 2006 | 36 | 0.070 |
Why?
|
| Mastectomy | 1 | 2006 | 56 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2006 | 85 | 0.070 |
Why?
|
| Gastroplasty | 1 | 2006 | 63 | 0.070 |
Why?
|
| Esophagogastric Junction | 1 | 2006 | 118 | 0.070 |
Why?
|
| Gastroscopy | 1 | 2006 | 45 | 0.070 |
Why?
|
| Fetal Weight | 1 | 2005 | 33 | 0.070 |
Why?
|
| Pneumonectomy | 1 | 2006 | 79 | 0.070 |
Why?
|
| Endoscopy, Digestive System | 1 | 2006 | 78 | 0.070 |
Why?
|
| Esophagostomy | 1 | 2005 | 3 | 0.070 |
Why?
|
| Gastric Fundus | 1 | 2005 | 8 | 0.070 |
Why?
|
| Gastrectomy | 1 | 2005 | 24 | 0.070 |
Why?
|
| Biopsy | 1 | 2007 | 539 | 0.070 |
Why?
|
| Collagen | 2 | 2006 | 636 | 0.070 |
Why?
|
| Fetal Organ Maturity | 1 | 2004 | 3 | 0.060 |
Why?
|
| Esophagus | 1 | 2006 | 303 | 0.060 |
Why?
|
| Endosonography | 1 | 2006 | 177 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 951 | 0.060 |
Why?
|
| Pregnancy, Prolonged | 1 | 2004 | 1 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2006 | 172 | 0.060 |
Why?
|
| Stents | 1 | 2009 | 657 | 0.060 |
Why?
|
| Gastrostomy | 1 | 2005 | 110 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2006 | 2550 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 2083 | 0.060 |
Why?
|
| Disease Progression | 1 | 2007 | 1037 | 0.060 |
Why?
|
| Young Adult | 1 | 2015 | 5708 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2009 | 1447 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2007 | 1341 | 0.060 |
Why?
|
| Endoscopy | 1 | 2006 | 464 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 3256 | 0.060 |
Why?
|
| Obesity | 1 | 2010 | 1074 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2004 | 880 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 1070 | 0.050 |
Why?
|
| Biomarkers | 1 | 2007 | 1593 | 0.050 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 78 | 0.050 |
Why?
|
| Rats | 2 | 2006 | 5300 | 0.050 |
Why?
|
| Brain | 1 | 2011 | 2175 | 0.050 |
Why?
|
| Sewage | 1 | 2019 | 23 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2007 | 3185 | 0.050 |
Why?
|
| Birth Weight | 1 | 2020 | 186 | 0.040 |
Why?
|
| Time Factors | 2 | 2005 | 4655 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2021 | 298 | 0.040 |
Why?
|
| White Matter | 1 | 2021 | 174 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 4843 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 689 | 0.040 |
Why?
|
| Didelphis | 2 | 2006 | 2 | 0.040 |
Why?
|
| Ligation | 2 | 2006 | 83 | 0.030 |
Why?
|
| Child | 1 | 2007 | 6400 | 0.030 |
Why?
|
| Equipment Design | 2 | 2008 | 500 | 0.030 |
Why?
|
| Manometry | 2 | 2006 | 276 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 911 | 0.030 |
Why?
|
| United States | 1 | 2007 | 7335 | 0.030 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2014 | 27 | 0.030 |
Why?
|
| Swine | 2 | 2006 | 672 | 0.030 |
Why?
|
| Decision Trees | 1 | 2013 | 74 | 0.030 |
Why?
|
| Infant Mortality | 1 | 2013 | 59 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2014 | 326 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2013 | 67 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 1026 | 0.030 |
Why?
|
| Gene Expression | 1 | 2014 | 770 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 503 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1548 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2010 | 101 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 129 | 0.020 |
Why?
|
| Colectomy | 1 | 2009 | 64 | 0.020 |
Why?
|
| ROC Curve | 1 | 2010 | 392 | 0.020 |
Why?
|
| Accidents, Occupational | 1 | 2008 | 16 | 0.020 |
Why?
|
| Equipment Safety | 1 | 2008 | 50 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 306 | 0.020 |
Why?
|
| Angiography | 1 | 2009 | 194 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2006 | 1615 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 244 | 0.020 |
Why?
|
| South Carolina | 1 | 2014 | 2750 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 579 | 0.020 |
Why?
|
| Peristalsis | 1 | 2006 | 76 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2006 | 91 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 260 | 0.020 |
Why?
|
| Omentum | 1 | 2006 | 18 | 0.020 |
Why?
|
| Pressure | 1 | 2006 | 252 | 0.020 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2006 | 20 | 0.020 |
Why?
|
| Microcirculation | 1 | 2006 | 77 | 0.020 |
Why?
|
| Ischemic Preconditioning | 1 | 2006 | 31 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2006 | 90 | 0.020 |
Why?
|
| Gastroepiploic Artery | 1 | 2005 | 2 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2005 | 12 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2006 | 62 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2006 | 216 | 0.020 |
Why?
|
| Atrophy | 1 | 2005 | 112 | 0.020 |
Why?
|
| Radiography | 1 | 2006 | 572 | 0.020 |
Why?
|
| Vasodilation | 1 | 2005 | 85 | 0.020 |
Why?
|
| Video Recording | 1 | 2006 | 145 | 0.020 |
Why?
|
| Catheterization | 1 | 2006 | 209 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2005 | 168 | 0.020 |
Why?
|
| Observer Variation | 1 | 2006 | 330 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 2006 | 120 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 507 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2006 | 164 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 219 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2006 | 652 | 0.020 |
Why?
|
| Enteral Nutrition | 1 | 2006 | 157 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 378 | 0.010 |
Why?
|
| Software | 1 | 2006 | 418 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 621 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2006 | 384 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 2004 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2006 | 1329 | 0.010 |
Why?
|